...
search icon
mrk-img

Merck & Company Inc Share Price

MRK
NYQ
$108.18
-$1
(-0.92%)
1D
Industry: Pharmaceuticals Sector: Health Care

Merck & Company Inc Analyst Forecast

Merck & Company Inc Share Price Chart

Merck & Company Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$270.99B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
14.6971
Volume info-icon
This is the total number of shares traded during the most recent trading day.
10.49M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
2.92%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.30
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$71.26 L
$112.9 H
$108.18

About Merck & Company Inc, Common Stock

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Merck & Company Inc Stock Returns

Time FrameMRKSectorS&P500
1-Week Return-0.6%1.64%-0.4%
1-Month Return2.99%2.13%0.14%
3-Month Return24.09%8.39%2.61%
6-Month Return28.82%16.16%8.7%
1-Year Return11.95%9.86%13%
3-Year Return-1.55%17.8%72.1%
5-Year Return39.71%33.74%79.31%
10-Year Return122.65%135.48%268.2%

Merck & Company Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue41.52B48.70B59.28B60.12B64.17B[{"date":"2020-12-31","value":64.7,"profit":true},{"date":"2021-12-31","value":75.9,"profit":true},{"date":"2022-12-31","value":92.39,"profit":true},{"date":"2023-12-31","value":93.68,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue13.62B13.63B17.41B16.13B15.19B[{"date":"2020-12-31","value":78.21,"profit":true},{"date":"2021-12-31","value":78.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.62,"profit":true},{"date":"2024-12-31","value":87.26,"profit":true}]
Gross Profit27.90B35.08B41.87B43.99B48.98B[{"date":"2020-12-31","value":56.97,"profit":true},{"date":"2021-12-31","value":71.62,"profit":true},{"date":"2022-12-31","value":85.5,"profit":true},{"date":"2023-12-31","value":89.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin67.20%72.02%70.63%73.17%76.32%[{"date":"2020-12-31","value":88.05,"profit":true},{"date":"2021-12-31","value":94.37,"profit":true},{"date":"2022-12-31","value":92.54,"profit":true},{"date":"2023-12-31","value":95.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses22.35B21.88B23.59B41.03B28.75B[{"date":"2020-12-31","value":54.47,"profit":true},{"date":"2021-12-31","value":53.32,"profit":true},{"date":"2022-12-31","value":57.49,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":70.07,"profit":true}]
Operating Income5.55B13.20B18.28B2.95B20.22B[{"date":"2020-12-31","value":27.44,"profit":true},{"date":"2021-12-31","value":65.27,"profit":true},{"date":"2022-12-31","value":90.41,"profit":true},{"date":"2023-12-31","value":14.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(457.00M)(90.00M)(2.64B)(1.75B)(1.14B)[{"date":"2020-12-31","value":-45700000000,"profit":false},{"date":"2021-12-31","value":-9000000000,"profit":false},{"date":"2022-12-31","value":-264300000000,"profit":false},{"date":"2023-12-31","value":-174600000000,"profit":false},{"date":"2024-12-31","value":-114100000000,"profit":false}]
Pre-Tax Income5.86B13.88B16.44B1.89B19.94B[{"date":"2020-12-31","value":29.41,"profit":true},{"date":"2021-12-31","value":69.62,"profit":true},{"date":"2022-12-31","value":82.48,"profit":true},{"date":"2023-12-31","value":9.48,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes1.34B1.52B1.92B1.51B2.80B[{"date":"2020-12-31","value":47.81,"profit":true},{"date":"2021-12-31","value":54.26,"profit":true},{"date":"2022-12-31","value":68.43,"profit":true},{"date":"2023-12-31","value":53.94,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes4.52B12.36B14.53B377.00M17.13B[{"date":"2020-12-31","value":26.4,"profit":true},{"date":"2021-12-31","value":72.13,"profit":true},{"date":"2022-12-31","value":84.78,"profit":true},{"date":"2023-12-31","value":2.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations7.08B12.36B14.53B4.62B17.13B[{"date":"2020-12-31","value":41.34,"profit":true},{"date":"2021-12-31","value":72.13,"profit":true},{"date":"2022-12-31","value":84.78,"profit":true},{"date":"2023-12-31","value":26.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations704.00M704.00M---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income7.07B13.05B14.52B365.00M17.12B[{"date":"2020-12-31","value":41.29,"profit":true},{"date":"2021-12-31","value":76.23,"profit":true},{"date":"2022-12-31","value":84.82,"profit":true},{"date":"2023-12-31","value":2.13,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)5.936.267.481.507.64[{"date":"2020-12-31","value":77.62,"profit":true},{"date":"2021-12-31","value":81.94,"profit":true},{"date":"2022-12-31","value":97.91,"profit":true},{"date":"2023-12-31","value":19.63,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Merck & Company Inc Ratios

Merck & Company Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

MRK
Cash Ratio 0.64
Current Ratio 1.66
Quick Ratio 1.44

Merck & Company Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MRK
ROA (LTM) 13.76%
ROE (LTM) 39.49%

Merck & Company Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MRK
Debt Ratio Lower is generally better. Negative is bad. 0.60
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.40

Merck & Company Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MRK
Trailing PE 14.70
Forward PE 11.82
P/S (TTM) 4.32
P/B 5.32
Price/FCF 41
EV/R 4.65
EV/Ebitda 10.81
PEG 1.17

FAQs

What is Merck & Company Inc share price today?

Merck & Company Inc (MRK) share price today is $108.18

Can Indians buy Merck & Company Inc shares?

Yes, Indians can buy shares of Merck & Company Inc (MRK) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MRK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Merck & Company Inc be purchased?

Yes, you can purchase fractional shares of Merck & Company Inc (MRK) via the Vested app. You can start investing in Merck & Company Inc (MRK) with a minimum investment of $1.

How to invest in Merck & Company Inc shares from India?

You can invest in shares of Merck & Company Inc (MRK) via Vested in three simple steps:

  • Click on Sign Up or Invest in MRK stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Merck & Company Inc shares
What is Merck & Company Inc 52-week high and low stock price?

The 52-week high price of Merck & Company Inc (MRK) is $112.9. The 52-week low price of Merck & Company Inc (MRK) is $71.26.

What is Merck & Company Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Merck & Company Inc (MRK) is 14.6971

What is Merck & Company Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Merck & Company Inc (MRK) is 5.32

What is Merck & Company Inc dividend yield?

The dividend yield of Merck & Company Inc (MRK) is 2.92%

What is the Market Cap of Merck & Company Inc?

The market capitalization of Merck & Company Inc (MRK) is $270.99B

What is Merck & Company Inc's stock symbol?

The stock symbol (or ticker) of Merck & Company Inc is MRK

How Can Investors Use Merck & Company Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Merck & Company Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Merck & Company Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Merck & Company Inc shares for Indian investors?

When investing in Merck & Company Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Merck & Company Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Merck & Company Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Merck & Company Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Merck & Company Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top